Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

Twenty-five years of progress in Parkinson's disease research: from dopamine replacement to biological definition and regenerative therapy.

Winkler J.

J Neural Transm (Vienna) · 2026-10-24

DOI: 10.1007/s00702-026-03308-8PMID: 42925426

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Unlocking therapeutic potential of Wnt signaling pathway in neurodegenerative diseases.

Shah A, Godad A, Bagwe Parab S.

Metab Brain Dis · 2026-10-24

DOI: 10.1007/s11011-026-02006-4PMID: 42925434

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Liquid-liquid phase separation in neurodegenerative diseases: Mechanisms, pathological transitions, and therapeutic opportunities.

Huang J, Zhang S, Zhang D, Yang T, Li C, He M, Wang J, Song T, Wang X, Lu Y, Kong Q, Tan J, Zhang J.

Sci Prog · 2026-10-23

DOI: 10.1177/00368504261499190PMID: 42913489

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Cellular senescence in ageing and neurodegenerative disorders: Molecular mechanisms, biomarkers, and therapeutic strategies.

Verma A, Goyal A, Agrawal N, Yadav HN.

Prog Neuropsychopharmacol Biol Psychiatry · 2026-10-23

DOI: 10.1016/j.pnpbp.2026.111985PMID: 42918387

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Neurodegenerative Diseases: Epidemiology, Risk Factors, Classification, Pathophysiology, Clinical Features, Diagnosis, and Therapeutic Strategies.

He Z, Zeng J, Wang G, Li Y, Zhang F.

MedComm (2020) · 2026-10-23

DOI: 10.1002/mco2.71090PMID: 42921272

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Targeting the microbiota-gut-brain axis in Alzheimer's and Parkinson´s disease: recent therapeutic approaches.

Gries M, Schäfer KH, Endres K.

Expert Opin Ther Targets · 2026-10-22

DOI: 10.1080/14728222.2026.2748747PMID: 42885915

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

TMEM106B risk converges on C-terminal fragment homeostasis: genetics, mechanisms and therapy.

Lastra Osua M, Perneel J, Vicente CT, Rademakers R.

Brain · 2026-10-22

DOI: 10.1093/brain/awag367PMID: 42910644

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Evaluating the NLRP3 inflammasome in chemotherapy-induced cognitive impairment: A multi-timepoint study of methotrexate and 5-fluorouracil in female rats.

Haller OJ, Carr LM, Semendric I, George RP, Whittaker AL, Collins-Praino LE.

Behav Brain Res · 2026-10-21

DOI: 10.1016/j.bbr.2026.116542PMID: 42906859

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Intelligent exogenous predictive networks for nonlinear Parkinson's disease model involving delay with effects of immunotherapy.

Chaudhary NI, Mukhtar A, Chaudhary II, Raja MAZ.

Comput Biol Chem · 2026-10-21

DOI: 10.1016/j.compbiolchem.2026.109501PMID: 42913159

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Brain Stimulation as a Treatment for Apathy: A Scoping Review of Effects and Safety.

Grewal P, Seidman MB, Chasen J, Lench D, Dickens I, Brennan EA, Rodriguez-Porcel F, Kindred J, George MS, Kautz S, Caulfield KA, McTeague LM.

J Neuropsychiatry Clin Neurosci · 2026-10-20

DOI: 10.1176/appi.neuropsych.20250297PMID: 42897722

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Neurodegeneration epicenters: Distinct network mechanisms of dopaminergic treatment in Parkinson's disease.

Duanmu X, Zhu Z, Lu N, Zhang W, Wang L, Wen J, Qin J, Tao Q, Jin Y, Zhou L, Zhou C, Guo T, Wu H, Chen J, Wu J, Yan Y, Tian J, Zhang M, Guan X, Xu X.

Neural Regen Res · 2026-10-20

DOI: 10.4103/nrr.nrronline-d-26-00811PMID: 42899897

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Nanomaterial Design for Macrophage Reprogramming: Emerging Strategies and Mechanistic Insights for Inflammation and Tumor Therapy.

Giri N, Chakraborty A.

ACS Appl Bio Mater · 2026-10-20

DOI: 10.1021/acsabm.6c01937PMID: 42900219

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

10.361 makale bulundu

Twenty-five years of progress in Parkinson's disease research: from dopamine replacement to biological definition and regenerative therapy.

Unlocking therapeutic potential of Wnt signaling pathway in neurodegenerative diseases.

Liquid-liquid phase separation in neurodegenerative diseases: Mechanisms, pathological transitions, and therapeutic opportunities.

Cellular senescence in ageing and neurodegenerative disorders: Molecular mechanisms, biomarkers, and therapeutic strategies.

Neurodegenerative Diseases: Epidemiology, Risk Factors, Classification, Pathophysiology, Clinical Features, Diagnosis, and Therapeutic Strategies.

Targeting the microbiota-gut-brain axis in Alzheimer's and Parkinson´s disease: recent therapeutic approaches.

TMEM106B risk converges on C-terminal fragment homeostasis: genetics, mechanisms and therapy.

Evaluating the NLRP3 inflammasome in chemotherapy-induced cognitive impairment: A multi-timepoint study of methotrexate and 5-fluorouracil in female rats.

Intelligent exogenous predictive networks for nonlinear Parkinson's disease model involving delay with effects of immunotherapy.

Brain Stimulation as a Treatment for Apathy: A Scoping Review of Effects and Safety.

Neurodegeneration epicenters: Distinct network mechanisms of dopaminergic treatment in Parkinson's disease.

Nanomaterial Design for Macrophage Reprogramming: Emerging Strategies and Mechanistic Insights for Inflammation and Tumor Therapy.

Filtreler